Startups
Edit
https://www.stevanatogroup.com/en/offering/drug-delivery-systems/proprietary-and-licensed-devices/sg-ez-be-pod/
Stevanato Group
TrustedLast activity: 17.09.2026
Active
Since 1949, one of the largest biopharma providers of integrated containment and delivery solutions.
Overview
Location
Switzerland, Zurich, Dübendorf
Employees
1001-5000
Total raised
$233.9M
Founded date
2013
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 13
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 26, 2025 | Stevanato Group: €200 Million In Funding Raised For Drug Solutions | Stevanato Group, a global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it has secured €200 million in financing through agreem... |
| Mar 16, 2023 | Stevanato Group collaborates with Resyca® to develop and manufacture pre-fillable syringes for use in a new soft mist inhaler for the inhalation of sensitive biological products | Stevanato Group collaborates with Resyca® to develop and manufacture pre-fillable syringes for use in a new soft mist inhaler for the inhalation of sensitive biological products Thu, Mar 16, 2023 14:00 CET Report this content The new strate... |
| Mar 16, 2023 | Stevanato Group collaborates with Recipharm to develop and manufacture pre-fillable syringes for use in a new soft mist inhaler for the inhalation of sensitive biological products | Stevanato Group collaborates with Recipharm to develop and manufacture pre-fillable syringes for use in a new soft mist inhaler for the inhalation of sensitive biological products Thu, Mar 16, 2023 14:00 CET Report this content The new stra... |
| Mar 9, 2023 | Stevanato Group Secures €130 Million ESG-Linked Financing From BNL BNP Paribas and Cassa Depositi e Prestiti to Support Sustainable Global Growth | Listen to this story: Stevanato Group A.p.A., a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, has announced two separate agreements with BNL BN... |
| Mar 8, 2023 | Stevanato Group Secures €130 Million ESG-Linked Financing to Support Sustainable Global Growth | Listen to this story: Stevanato Group S.p.A., a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced two separate agreements with BNL BNP Pa... |
| Nov 1, 2022 | Gerresheimer AG and Stevanato Group present EZ-fill Smart™, a new and innovative Ready-To-Fill Vial Platform | DÜSSELDORF, Germany and PIOMBINO DESE, Italy, Nov. 1, 2022 /PRNewswire/ -- Gerresheimer AG, a leading global provider of healthcare & beauty and drug delivery systems for pharma, biotech and cosmetics and Stevanato Group S.p.A., a globa... |
| Mar 10, 2022 | Q&A: Franco Stevanto leads family business through pandemic, IPO and onto the global stage | As the US government continues to dump money into vial and packaging manufacturing, Italian vial manufacturer Stevanato Group has taken full advantage. It broke ground in October on a $145 million manufacturing site in Fishers, IN to bring ... |
| Mar 2, 2022 | Months after IPO, Italian vial company lands BARDA investment as government looks to shore up pandemic preparedness | BARDA has enlisted the help of an Italian drug containment company to expand its manufacturing capacity in Fishers, IN for vial production, the company announced Tuesday. Stevanato will get $95 million from the Department of Defense through... |
| Nov 4, 2021 | Stevanato Group to showcase the benefits of an integrated solutions approach at CPhI Worldwide Conference, November 9-11 | Spotlight on the development of proprietary devices like the SG Alina pen injector platform Piombino Dese (PD), Italy, November 4, 2021 - Stevanato Group, a leading global provider of drug containment, drug delivery, and diagnostic solution... |
Show more
Reviews 0
FAQ about Stevanato Group
When was Stevanato Group founded?
Stevanato Group was founded in 2013.
How much funding has Stevanato Group raised?
Stevanato Group has raised $233.9M in total across 1 funding round.
What has the press written about Stevanato Group?
Parsers VC has collected 13 articles mentioning Stevanato Group, among them “Stevanato Group: €200 Million In Funding Raised For Drug Solutions” (Jul 26, 2025) and “Stevanato Group collaborates with Resyca® to develop and manufacture pre-fillable syringes for use in a new soft mist inhaler for the inhalation of sensitive...” (Mar 16, 2023).
Is Stevanato Group still active?
Yes, Stevanato Group is active; its latest activity on Parsers VC dates from Sep 17, 2026.